The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials-Reference-Cited by-同舟云学术

The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials

Published:2017-10-20 Issue:60 Volume:8 Page:102371-102380
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Bum Jun¹²,Jeong Jae Ho³,Kim Hyeong Su¹,Kim Jung Han¹

Affiliation:

1. Division of Hemato-Oncology, Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea

2. Division of Internal Medicine, National Army Capital Hospital, The Armed Forces Medical Command, Sungnam, Republic of Korea

3. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoradiotherapy in Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma. Cetuximab is Inferior to Cisplatin – is the Case now Closed?;Clinical Oncology;2022-12

2. NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models;Cancers;2022-01-20

3. The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy;Frontiers in Oncology;2021-09-10

4. Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck;Frontiers in Oncology;2020-05-27

5. Graphene oxide-based nanocomposite enabled highly efficient targeted synergistic therapy for colorectal cancer;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2020-05